- Micro cap Zogenix (ZGNX +8.1%) gives long-suffering longs a bit of hope today on a 2.5x surge in volume. Shares plummeted 79% from the February 13 high of $5.19 to the December 16 low of $1.08.
- Yesterday, Brean Capital initiated coverage with a Buy rating and $2.50 price target.
- The PDUFA date for its sNDA for an abuse deterrent formulation of Zohydro ER (hydrocodone bitartrate) is January 30.
- Previously: Zogenix submits sNDA for abuse deterrent Zohydro (Oct. 1)